☰

Carolina Haass-Koffler - Publications

Affiliations: 
Department of Neuroscience Brown University, Providence, RI 
Tree Info Grants Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Nelson MJ, Soliman PS, Rhew R, Cassidy RN, Haass-Koffler CL. Disruption of circadian rhythms promotes alcohol use: a systematic review. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 38123479 DOI: 10.1093/alcalc/agad083  0.573
2023 Gully BJ, Eaton E, Capone C, Haass-Koffler CL. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy. Journal of Psychopharmacology (Oxford, England). 2698811231200880. PMID 38009477 DOI: 10.1177/02698811231200880  0.488
2023 Soliman P, Amaefuna I, Gully B, Haass-Koffler CL. Evaluating the Readability of Online Patient Facing Resources for Alcohol Use Disorder. Alcohol (Fayetteville, N.Y.). PMID 37661000 DOI: 10.1016/j.alcohol.2023.08.012  0.353
2023 Haass-Koffler CL, Magill M, Cannella N, Brown JC, Aoun EG, Cioe PA, Sinha R, Swift RM, Ciccocioppo R, Leggio L. Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study. Addiction Biology. 28: e13288. PMID 37369125 DOI: 10.1111/adb.13288  0.595
2023 Haass-Koffler CL. Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist. Alcoholism, Clinical and Experimental Research. 47: 432-434. PMID 36852535 DOI: 10.1111/acer.15014  0.531
2023 Haass-Koffler CL, Magill M, Cannella N, Brown JC, Aoun EG, Cioe PA, Sinha R, Swift RM, Ciccocioppo R, Leggio L. Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial. Medrxiv : the Preprint Server For Health Sciences. PMID 36711869 DOI: 10.1101/2023.01.02.23284122  0.604
2022 Haass-Koffler CL, Francis TC, Gandhi P, Patel R, Naemuddin M, Nielsen CK, Bartlett SE, Bonci A, Vasile S, Hood BL, Suyama E, Hedrick MP, Smith LH, Limpert AS, Roberto M, et al. Development and Use of a High-Throughput Screen to Identify Novel Modulators of the Corticotropin Releasing Factor Binding Protein. Slas Discovery : Advancing Life Sciences R & D. PMID 36210051 DOI: 10.1016/j.slasd.2022.09.005  0.309
2022 Curley DE, Vasaturo-Kolodner TR, Cannella N, Ciccocioppo R, Haass-Koffler CL. Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35760866 DOI: 10.1038/s41386-022-01363-9  0.592
2022 Varodayan FP, Patel RR, Matzeu A, Wolfe SA, Curley DE, Khom S, Gandhi PJ, Rodriguez L, Bajo M, D'Ambrosio S, Sun H, Kerr TM, Gonzales RA, Leggio L, Natividad LA, ... Haass-Koffler CL, et al. The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder. Biological Psychiatry. PMID 35430085 DOI: 10.1016/j.biopsych.2022.02.006  0.606
2021 Curley DE, Webb AE, Sheffler DJ, Haass-Koffler CL. Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research. Frontiers in Behavioral Neuroscience. 15: 786855. PMID 34912198 DOI: 10.3389/fnbeh.2021.786855  0.599
2021 Haass-Koffler CL, Perciballi R, Magill M, Loche A, Cacciaglia R, Leggio L, Swift RM. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder. Psychopharmacology. PMID 34731268 DOI: 10.1007/s00213-021-06008-1  0.615
2021 Goodyear K, Vasaturo-Kolodner TR, Kenna GA, Swift RM, Leggio L, Haass-Koffler CL. Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder. The American Journal of Drug and Alcohol Abuse. 47: 760-768. PMID 34582281 DOI: 10.1080/00952990.2021.1961799  0.411
2021 Farokhnia M, Abshire KM, Hammer A, Deschaine SL, Saravanakumar A, Cobbina E, You ZB, Haass-Koffler CL, Lee MR, Akhlaghi F, Leggio L. Neuroendocrine response to exogenous ghrelin administration, combined with alcohol, in heavy-drinking individuals: Findings from a randomized, double-blind, placebo-controlled human laboratory study. The International Journal of Neuropsychopharmacology. PMID 33560411 DOI: 10.1093/ijnp/pyab004  0.643
2021 Brown ZE, Portis SM, Fleig CL, Vasaturo-Kolodner T, Swift RM, Haass-Koffler CL. Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic. Alcohol (Fayetteville, N.Y.). PMID 33434615 DOI: 10.1016/j.alcohol.2021.01.001  0.446
2021 Stopponi S, Fotio Y, Cifani C, Li H, Haass-Koffler CL, Cannella N, Demopulos G, Gaitanaris G, Ciccocioppo R. Andrographis paniculata and Its Main Bioactive Ingredient Andrographolide Decrease Alcohol Drinking and Seeking in Rats Through Activation of Nuclear PPARγ Pathway. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 33401299 DOI: 10.1093/alcalc/agaa136  0.432
2020 Portis SM, Haass-Koffler CL. New Microglial Mechanisms Revealed in Alcohol Use Disorder: How Does That Translate? Biological Psychiatry. 88: 893-895. PMID 33213701 DOI: 10.1016/j.biopsych.2020.08.025  0.603
2020 Haass-Koffler CL, Piacentino D, Li X, Long VM, Lee MR, Swift RM, Kenna GA, Leggio L. Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study of Alcohol Use Disorder. Alcoholism, Clinical and Experimental Research. PMID 32997422 DOI: 10.1111/acer.14428  0.584
2020 Haass-Koffler CL, Souza RD, Wilmott JP, Aston ER, Song JH. A Combined Alcohol and Smoking Cue-Reactivity Paradigm in People Who Drink Heavily and Smoke Cigarettes: Preliminary Findings. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 32984874 DOI: 10.1093/alcalc/agaa089  0.408
2020 Haass-Koffler CL, Perciballi R, Brown ZE, Lee MR, Zywiak WH, Kurtis J, Swift RM, Leggio L. Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β-Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders. The American Journal On Addictions. PMID 32488890 DOI: 10.1111/Ajad.13064  0.481
2020 Haass-Koffler CL. Protein Tyrosine Phosphatase β/ζ and Alcohol Use Disorder: A Commentary. Alcoholism, Clinical and Experimental Research. 44: 1189-1191. PMID 32343842 DOI: 10.1111/acer.14346  0.516
2020 Haass-Koffler CL, Cannella N, Ciccocioppo R. Translational dynamics of alcohol tolerance of preclinical models and human laboratory studies. Experimental and Clinical Psychopharmacology. PMID 32212746 DOI: 10.1037/Pha0000366  0.598
2020 Haass-Koffler CL, Schank JR. Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31965552 DOI: 10.1007/S13311-020-00833-6  0.62
2020 Haass-Koffler CL, Perciballi R. Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder. Alcohol and Alcoholism (Oxford, Oxfordshire). 55: 129-135. PMID 31950152 DOI: 10.1093/alcalc/agz103  0.585
2019 Tunstall BJ, Lorrai I, McConnell SA, Gazo KL, Zallar LJ, de Guglielmo G, Hoang I, Haass-Koffler CL, Repunte-Canonigo V, Koob GF, Vendruscolo LF, Sanna PP. Probenecid Reduces Alcohol Drinking in Rodents. Is Pannexin1 a Novel Therapeutic Target for Alcohol Use Disorder? Alcohol and Alcoholism (Oxford, Oxfordshire). 54: 497-502. PMID 31535696 DOI: 10.1093/alcalc/agz054  0.571
2019 Haass-Koffler CL, Long VM, Farokhnia M, Magill M, Kenna GA, Swift RM, Leggio L. Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study. Neuropharmacology. 107711. PMID 31310775 DOI: 10.1016/j.neuropharm.2019.107711  0.522
2018 Haass-Koffler CL, Goodyear K, Zywiak WH, Leggio L, Kenna GA, Swift RM. Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29718153 DOI: 10.1093/alcalc/agy030  0.461
2018 Haass-Koffler CL. The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system? Alcohol (Fayetteville, N.Y.). 72: 3-8. PMID 29510883 DOI: 10.1016/j.alcohol.2017.10.001  0.63
2018 Haass-Koffler CL, Swift RM, Leggio L. Noradrenergic targets for the treatment of alcohol use disorder. Psychopharmacology. PMID 29460163 DOI: 10.1007/s00213-018-4843-6  0.562
2018 Haass-Koffler CL, Goodyear K, Loche A, Long VM, Lobina C, Tran HH, Cacciaglia R, Swift RM, Colombo G, Leggio L. Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET7 3 with alcohol: A translational study in rats and humans. Journal of Psychopharmacology (Oxford, England). 269881117746904. PMID 29361897 DOI: 10.1177/0269881117746904  0.52
2017 Haass-Koffler CL, Goodyear K, Zywiak WH, Leggio L, Kenna GA, Swift RM. Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29281033 DOI: 10.1093/alcalc/agx108  0.38
2017 Haass-Koffler CL, Goodyear K, Zywiak WH, Magill M, Eltinge SE, Wallace PM, Long VM, Jayaram-Lindström N, Swift RM, Kenna GA, Leggio L. Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. Drug and Alcohol Dependence. 177: 23-28. PMID 28551590 DOI: 10.1016/j.drugalcdep.2017.03.016  0.548
2017 Haass-Koffler CL, Akhlaghi F, Swift RM, Leggio L. Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks? Journal of Psychopharmacology (Oxford, England). 269881116684338. PMID 28093021 DOI: 10.1177/0269881116684338  0.572
2016 Haass-Koffler CL, Giovenco DE, Lee MR, Zywiak WH, de la Monte SM, Kenna GA, Swift RM, Leggio L. Serum Insulin Levels are Reduced by Intravenous Ghrelin Administration but do not Correlate with Alcohol Craving in Alcohol Dependent Individuals. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 27207912 DOI: 10.1093/ijnp/pyw048  0.445
2015 Kenna GA, Haass-Koffler CL, Zywiak WH, Edwards SM, Brickley MB, Swift RM, Leggio L. Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial. Addiction Biology. PMID 26037245 DOI: 10.1111/adb.12275  0.415
2015 Haass-Koffler CL, Leggio L, Davidson D, Swift RM. Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study. Alcoholism, Clinical and Experimental Research. 39: 594-602. PMID 25833022 DOI: 10.1111/Acer.12658  0.565
2015 Aoun EG, Lee MR, Haass-Koffler CL, Swift RM, Addolorato G, Kenna GA, Leggio L. Relationship between the thyroid axis and alcohol craving. Alcohol and Alcoholism (Oxford, Oxfordshire). 50: 24-9. PMID 25433251 DOI: 10.1093/alcalc/agu085  0.414
2014 Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L. Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings. Alcohol (Fayetteville, N.Y.). 48: 515-22. PMID 25212749 DOI: 10.1016/J.Alcohol.2014.04.005  0.336
2014 Vuittonet CL, Halse M, Leggio L, Fricchione SB, Brickley M, Haass-Koffler CL, Tavares T, Swift RM, Kenna GA. Pharmacotherapy for alcoholic patients with alcoholic liver disease. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 71: 1265-76. PMID 25027533 DOI: 10.2146/ajhp140028  0.455
2014 Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Vuittonet C, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study. Alcoholism, Clinical and Experimental Research. 38: 1567-74. PMID 24773166 DOI: 10.1111/Acer.12410  0.426
2014 Haass-Koffler CL, Leggio L, Kenna GA. Pharmacological approaches to reducing craving in patients with alcohol use disorders. Cns Drugs. 28: 343-60. PMID 24573997 DOI: 10.1007/s40263-014-0149-3  0.624
2013 Haass-Koffler CL, Kenna GA. Bacchus by Caravaggio as the Visual Diagnosis of Alcohol Use Disorder from the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Frontiers in Psychiatry. 4: 86. PMID 23964247 DOI: 10.3389/fpsyt.2013.00086  0.459
2012 Haass-Koffler CL, Bartlett SE. Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. Frontiers in Molecular Neuroscience. 5: 91. PMID 22973190 DOI: 10.3389/Fnmol.2012.00091  0.401
Show low-probability matches.